2DELLINGER RP,LEVY MM, RHODES A, et al. Surviving sepsis campaign: international guidelines for management of se- vere sepsis and septic shock:2012[J]. Crit Care Med, 2013, 41 (2) :580-637.
3ADHIKARI NK, FOWLER RA, BHAGWANJEE S, et al. Critical care and the global burden of critical illness in adults[J].Lancet, 2010, 376(9749):1339-1346.
4CHENG B,XIE G, YAO S, et al. Epidemiology or" severe sepsis in critically ill surgieai patients in ten university hospitals in Chi- na[J]. Crit Care Med, 2007, 35(11):2538-2546.
5ANDREW N. C, DANIEL T. The economies of sepsis[J]. Crit Care Clin, 2012, 28:2857-2876.
6LEVY MM, ARTIGAS A, PHILLIPS GS, et ai. Outcomes of the surviving sepsis campaign in intensive care units in the usa and europe: a prospective cohort study[J]. Lancet Infect, 2012, 12:919- 924.
7WAGENLEHNER F ME, LICHTENSTERN C, ROLFES C, et al. Diagnosis and management for urosepsis[J/OL]. Int J Urol, 2013, doi,10. 1111/iju. 12200:1-8.
8VAHLENSIECK W. Infizierte Harnstauungsniere und Pyone- phrose[M] ft. Facharztwissen Urologic. Heidelberg: Springer, 2006 : 24.
9WAGENLEHNER FME, PILATZ A, NABER KG, et al. Therapeutic challenges of urosepsis[J]. Eur J Clin Invest, 2008, 38 (S2) :45-49.
10RIVERS E, NGUYEN B, HAVSTAD S, et al, Early Goal-Di- rected TherapyCollaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock[J]. N Engl J Med, 2001, 345:1368-1377.
